Stem cells are critical for the maintenance of many tissues, but whether their integrity is maintained in the face of immunity is unclear. Here we found that cycling epithelial stem cells, including Lgr5+ intestinal stem cells, as well as ovary and mammary stem cells, were eliminated by activated T cells, but quiescent stem cells in the hair follicle and muscle were resistant to T cell killing. Immune evasion was an intrinsic property of the quiescent stem cells resulting from systemic downregulation of the antigen presentation machinery, including MHC class I and TAP proteins, and is mediated by the transactivator NLRC5. This process was reversed upon stem cell entry into the cell cycle. These studies identify a link between stem cell quiescence, antigen presentation, and immune evasion. As cancer-initiating cells can derive from stem cells, these findings may help explain how the earliest cancer cells evade immune surveillance.
Pubmed ID: 29466757 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets H-2Kd
View all literature mentionsThis unknown targets
View all literature mentionsThis unknown targets
View all literature mentionsThis isotype control targets HRP
View all literature mentionsThis monoclonal targets CD25 (IL-2Rα)
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets beta-2-Microglobulin (S19.8)
View all literature mentionsThis monoclonal targets CD106 (VCAM-1)
View all literature mentionsThis monoclonal targets CD31 (PECAM-1)
View all literature mentionsThis monoclonal targets CD31 (PECAM-1)
View all literature mentionsThis monoclonal targets Ly-6A/E (Sca-1)
View all literature mentionsThis monoclonal targets Ly-6A/E (Sca-1)
View all literature mentionsThis monoclonal targets CD49f (Integrin alpha 6)
View all literature mentionsThis monoclonal targets CD49f (Integrin alpha 6)
View all literature mentionsThis monoclonal targets CD24
View all literature mentionsThis monoclonal targets CD24
View all literature mentionsThis monoclonal targets MHC Class I (H-2Kd)
View all literature mentionsThis monoclonal targets MHC Class I (H-2Kd)
View all literature mentionsThis monoclonal targets MHC Class I (H-2Kd)
View all literature mentionsThis monoclonal targets MHC Class I (H-2Kb)
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets LRIG1
View all literature mentionsThis polyclonal targets Green Fluorescent Protein (GFP)
View all literature mentionsThis polyclonal targets CD207
View all literature mentionsThis monoclonal targets CD34
View all literature mentionsThis monoclonal targets H-2Kd
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets H-2Kd
View all literature mentions